Nicholson, Tom – Trademark Portfolio
Entity Type: 01
Nicholson, Tom holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PASSTRAC. The owner is based in Johnston, IA.
9245 Northpark Drive
Johnston, IA 50131
Showing of trademarks Trademarks
Trademark Classifications
Nicholson, Tom's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Nicholson, Tom have?
Nicholson, Tom has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 1 cancelled.
What trademark classes does Nicholson, Tom file in?
Nicholson, Tom files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Nicholson, Tom's most well-known trademarks?
Nicholson, Tom's registered trademark portfolio includes well-known marks such as PASSTRAC. These are among 1 currently registered trademark in the portfolio.
What is Nicholson, Tom's trademark registration success rate?
Nicholson, Tom has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.